Several clinical trials are
testing cell replacement therapies to treat spinal cord injuries.
Not exact matches
As well as allowing the use of stem
cells grown from established
cell lines, the technology could enable the creation of improved human tissue models for drug
testing and potentially even purpose - built
replacement organs.
Last year, Marson and Schumann successfully used CRISPR to perform precise DNA sequence
replacements in primary human T
cells for the first time by prefabricating the CRISPR machinery in
test tubes, then adding it to the freshly donated immune
cells.
A St. Louis orthopedic researcher has developed a way to grow a hip
replacement out of stem
cells found in a patient's fat reserves, and is now
testing it in animals.
In 2017, ViaCyte, Inc. announced the allowance of clinical
testing for its PEC - Direct
cell replacement product candidate for high - risk type 1 diabetes.
Information on the clinical
testing of ViaCyte's implantable
cell replacement therapies can be found at Clinicaltrials.gov.
The VC - 01 product candidate is the first embryonic stem
cell - derived islet
replacement therapy to reach clinical
testing and is currently being evaluated in patients with T1D who have minimal to no insulin - producing beta
cell function.
A lead engineer from the Department of Energy whose team is
testing fuel
cell cars said in 2011 that the potential appeal is that «these are full - function vehicles with no limitations on range or refueling rate so they are a direct
replacement for any vehicle.
It's been proved in Geekbench
tests that phones with degraded batteries have slower CPU speeds than iPhones with new battery
cells, as a battery
replacement would increase the CPU and the respective
test scores.